WKN DE: A40NKA / ISIN: CNE100005NM2

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Jiangsu Cowin Biotech a Times and Sales (SHA)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Jiangsu Cowin Biotech Co., Ltd. Registered Shs -A-

Weitere Meldungen

19:30		Is Nike Still a Growth Stock? Here's the Answer.
19:20		Broadcom vs. Dell Technologies: Which Stock Is AI Powering to Be a Better Buy in 2026?
19:20		Airbnb vs. Chewy: Do Pets or Places Power One Stock More than the Other?
19:19		Bloom Energy Raised Its 2026 Forecast for the Third Time. Is the Stock a Buy More Than a Third Below Its Record?
19:17		Apple Joins Nvidia in the $5 Trillion Club. Here's Which Stock I Think Can Get to $10 Trillion First.
19:11		Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?
19:08		Inflation Is Running Hotter Than Expected. That Could Be Bullish for Bitcoin.
19:07		Honeywell Technologies: 3 Key Takeaways for Long-Term Investors
19:06		Six Flags to Add Seatbelts on Roller Coasters After Rider’s Death
19:03		Why Appian Stock Surged 24.2% This Week
19:03		Conifer Management Buys $16.9 Million Group 1 Automotive Shares. What Does This Mean for Investors?
18:45		Social Security's 2027 COLA Is One of the Highest in Decades, but There Are Still 2 Issues Retirees May Run Into
18:30		2 Reasons You May Want to Switch to a Medicare Advantage Plan -- and 2 Reasons Not to
18:20		SAP: 3 Key Takeaways for Long-Term Investors
18:19		BGH: Auch Textnachrichten können sexuellen Missbrauch per Chat begründen
18:15		Celestica Stock Dips as the AI Trade Unwinds: Can Earnings Turn It Around?
18:15		Prediction: 2 Stocks That Will Be Worth More Than IonQ 5 Years From Now
18:13		Why Hasbro Stock Surged This Week
18:11		Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
18:01		Booking vs. Home Depot: Is Consumer Travel or Home Improvement Benefitting One of These Stocks More?
17:59		German national facing trial for alleged attempt to join IS
17:44		Kim reaffirms ties with China amid worries over Russian friendship
17:43		Could Redwire Be the Next Rocket Lab?
17:30		JetBlue Stock Sinks, Bond Yields Surge as Creditors Hire Advisors Amid Higher Jet Fuel Prices
17:23		Social Security's 2027 COLA Was Just Announced, but There Are 2 Other Key Changes to Be Aware of -- Even if You're Not Currently Receiving Benefits
17:20		Alibaba vs. Dick's Sporting Goods: Are Sporting Goods Thriving in the U.S. or Asia in 2026?
17:15		Chevron, Exxon, Shell and ConocoPhillips Hit Record Highs as Crude Rally Powers On Into Earnings
17:15		Can Amazon Take Market Share From Nvidia in the AI Chip Race?
17:14		Noah Adams, Longtime Host of ‘All Things Considered,’ Has Died at 84
17:07		The Nasdaq-100 Had Its Worst Week in 18 Months. History Says the Following Year Has Usually Been Strong.
16:45		Sandisk's New Business Model Is Transforming the Business. Now Is the Time to Buy the Stock.
16:30		Bill Ackman and Elon Musk Both Want Dinner With the Same Founding Father
16:03		Live: Fresh protests hit France amid heightened security
16:00		Anthony Scaramucci Once Shared This Cautionary Tale for Navigating Personal and Business Relationships — Crypto Bull Warns ‘You Can’t Put Your Pride and Ego’ Into Decisions
15:46		SpaceX Just Posted Its First Profitable Quarter. Is Now the Time to Buy the Stock?
15:28		My niece’s college rent is covered by a 529 plan. What else can I pay for tax-free?
15:27		Mayfair club Maison Estelle set to reopen after alleged firearm incident
15:02		Micron vs. Sandisk: Which Is the Better AI Memory Stock to Own for the Next 3 Years
15:00		EXCLUSIVE: A SpaceX-Tesla Merger Could Boost Passive ETF Demand, But ERShares’ Joel Shulman Flags a Big Risk
14:30		Tesla, SpaceX, Micron and More: 5 Stocks Investors Couldn't Stop Buzzing About This Week
14:26		Is MP Materials Stock a Millionaire Maker?
14:15		Chevron Is Taking a $3 Billion to $4 Billion Loss on Hess Midstream. Should You Buy the Stock Anyway?
14:06		XLRE vs VNQI: Domestic Large-Cap Stability or International 5% Yield
14:00		Benzinga Bulls and Bears: SpaceX, Meta, Netflix
14:00		C.E.O.s Say the A.I. Rollout Is Going Well. Employees Feel Differently.
14:00		AI fever ignites a boom in thematic ETFs as fund managers hunt for their next big hit
13:52		I'd Put Most of a Lump Sum Into an S&P 500 Fund Right Away. Here's When I Wouldn't.
13:42		U.S. Power Demand Is Set to Jump 20% by 2030. Here's What It Means for Energy Stocks.
13:37		OpenAI stellt seine neue Trainingsumgebung vor - ohne Air Gap
13:30		Breakfast News: A Conversation With Moderna’s CEO

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Pegasus Resources Learning 2 Sleep L2S AB Registered Shs Issue 2023 Norse Atlantic ASA Registered Shs Aebi Schmidt Tissue Regenix Group

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 81% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	24.10.2026 19:38
Kaufwert:	EUR
	Hinzufügen Speichern

Jiangsu Cowin Biotech a Aktie

WKN DE: A40NKA / ISIN: CNE100005NM2

Jiangsu Cowin Biotech a Times and Sales (SHA)

Times and Sales

Analysen zu Jiangsu Cowin Biotech Co., Ltd. Registered Shs -A-

Weitere Meldungen